3rd Annual Biocompatibility Testing In Medical Devices 2026 Conference
- 05 - 06 March 2026
CLIN-r+ are delighted to announce their participation at the 3rd Annual Biocompatibility Testing In Medical Devices 2026 Conference!
Our Director of Clinical and Regulatory Affairs, Jacqueline van Druten will be discussing EU and FDA’s Early Views since ISO 10993-1:2025 and ISO 18562-1:2024 release. First-hand insight into how the EU and FDA is applying the new standards in respiratory devices.
Date 05 March 2026 | Time: 10:10 -10:50am | Duration 20min and 10min Q&A
Available in person and online.
Our Clinical & Regulatory Affairs Director will deliver a timely and practical update on how regulators are applying the newly released ISO 10993-1:2025 and ISO 18562-1:2024 standards in real-world submissions. Drawing from recent FDA feedback and EU MDR review experience, this session will unpack emerging audit trends, evidence expectations, and common gaps being identified in respiratory and gas pathway devices. Attendees will gain first-hand insight into how benefit-risk is being interpreted, what regulators are prioritising post-update, and how to proactively align biological evaluation strategies to avoid delays and findings.
About the 3rd Annual Biocompatibility Testing In Medical Devices 2026 Conference
The 3rd Annual Biocompatibility Testing in Medical Devices Conference is designed to address the latest advancements, regulatory changes, and challenges in ensuring the safety of medical devices. As regulatory frameworks such as ISO 10993, EU MDR, and FDA guidelines continue to evolve, manufacturers, toxicologists, notified bodies, and regulatory professionals must adapt to meet compliance requirements and ensure product safety.
This year’s event will focus on:
– The latest regulatory requirements for biocompatibility testing and toxicological risk assessment
– Innovative testing methodologies, including in vitro models, organ-on-a-chip, and AI-driven approaches
– Best practices for extractables & leachables (E&L) analysis and chemical characterization
– Material selection and safety considerations for novel medical device technologies
– Risk-based approaches to cytotoxicity, sensitization, and genotoxicity assessment
Through interactive panel discussions, case study presentations, and hands-on workshops, attendees will gain practical insights into effective strategies for biocompatibility assessment and ensuring compliance with global regulations.
Join us in beautiful Rome for a conference that will shape
MORE INFO ON THE CONFERENCE:
toxicology@creovateconferences.com | +91 9908880832 | creovateconferences.com